InsidersTradesSigma
Track the Celon Pharma S.A. stock price and the full directors' dealings record of the company, a publicly traded company based in Poland. Shares are quoted on the PL market, under the supervision of KNF. Operating in the Health Care sector, Celon Pharma S.A. has logged 2 insider filings. Market capitalisation: €871.6m. The latest transaction was disclosed on 28 August 2026 (Purchase). Among the most active insiders: Justyna Rejmak. The full history is openly available.
Analysts rate Celon Pharma S.A. Hold (neutral), based on 5 analysts. Average price target: PLN 20.44.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Celon Pharma S.A. 是一家专注于医疗保健和制药领域创新药物开发的公司。它在XWAR市场上市。